McCurdy, S., Keedy, K., Lawrence, L., Nenninger, A., Sheets, A., Quintas, M., & Cammarata, S. (2020). Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial. Antimicrob Agents Chemother.
Chicago-tyylinen lähdeviittausMcCurdy, Sandra, Kara Keedy, Laura Lawrence, Ashley Nenninger, Amanda Sheets, Megan Quintas, ja Sue Cammarata. "Efficacy of Delafloxacin Versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results From the Delafloxacin Phase 3 CABP Trial." Antimicrob Agents Chemother 2020.
MLA-viiteMcCurdy, Sandra, et al. "Efficacy of Delafloxacin Versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults With Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results From the Delafloxacin Phase 3 CABP Trial." Antimicrob Agents Chemother 2020.